385 related articles for article (PubMed ID: 35053454)
1. Claudins and Gastric Cancer: An Overview.
Hashimoto I; Oshima T
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053454
[TBL] [Abstract][Full Text] [Related]
2. Claudins and hepatocellular carcinoma.
Wang W; Zhou Y; Li W; Quan C; Li Y
Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
4. Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.
Grizzi G; Venetis K; Denaro N; Bonomi M; Celotti A; Pagkali A; Hahne JC; Tomasello G; Petrelli F; Fusco N; Ghidini M
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109309
[TBL] [Abstract][Full Text] [Related]
5. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
[TBL] [Abstract][Full Text] [Related]
6. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
Zhou S; Piao X; Wang C; Wang R; Song Z
Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
[TBL] [Abstract][Full Text] [Related]
7. Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis.
Alghamdi RA; Al-Zahrani MH
Front Genet; 2023; 14():1221815. PubMed ID: 37799140
[TBL] [Abstract][Full Text] [Related]
8. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study.
Dottermusch M; Krüger S; Behrens HM; Halske C; Röcken C
Virchows Arch; 2019 Nov; 475(5):563-571. PubMed ID: 31332522
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of claudins in patients with triple-negative breast cancer are associated with nodal metastasis and worse outcome.
Katayama A; Handa T; Komatsu K; Togo M; Horiguchi J; Nishiyama M; Oyama T
Pathol Int; 2017 Aug; 67(8):404-413. PubMed ID: 28699235
[TBL] [Abstract][Full Text] [Related]
10. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
Jia H; Chai X; Li S; Wu D; Fan Z
Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of claudins in maintaining the integrity of epididymal tight junctions using novel human epididymal cell lines.
Dubé E; Dufresne J; Chan PT; Hermo L; Cyr DG
Biol Reprod; 2010 Jun; 82(6):1119-28. PubMed ID: 20164436
[TBL] [Abstract][Full Text] [Related]
12. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
14. Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?
Łukaszewicz-Zając M; Mroczko B
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201579
[TBL] [Abstract][Full Text] [Related]
15. The Significance of the
Zhang WH; Zhang SY; Hou QQ; Qin Y; Chen XZ; Zhou ZG; Shu Y; Xu H; Hu JK
Front Oncol; 2020; 10():1214. PubMed ID: 32983960
[No Abstract] [Full Text] [Related]
16. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J
Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412
[TBL] [Abstract][Full Text] [Related]
17. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
[TBL] [Abstract][Full Text] [Related]
18. Claudin immunolocalization in neonatal mouse epithelial tissues.
Troy TC; Arabzadeh A; Yerlikaya S; Turksen K
Cell Tissue Res; 2007 Nov; 330(2):381-8. PubMed ID: 17828607
[TBL] [Abstract][Full Text] [Related]
19. Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion.
Angerilli V; Ghelardi F; Nappo F; Grillo F; Parente P; Lonardi S; Luchini C; Pietrantonio F; Ugolini C; Vanoli A; Fassan M
Pathol Res Pract; 2024 Feb; 254():155145. PubMed ID: 38277741
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.
Nakayama I; Shinozaki E; Sakata S; Yamamoto N; Fujisaki J; Muramatsu Y; Hirota T; Takeuchi K; Takahashi S; Yamaguchi K; Noda T
Cancer Sci; 2019 Apr; 110(4):1352-1363. PubMed ID: 30771244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
